chr13-51941218-A-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000053.4(ATP7B):ā€‹c.3419T>Cā€‹(p.Val1140Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.579 in 1,613,484 control chromosomes in the GnomAD database, including 271,848 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.57 ( 24911 hom., cov: 30)
Exomes š‘“: 0.58 ( 246937 hom. )

Consequence

ATP7B
NM_000053.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts U:1B:19

Conservation

PhyloP100: 0.0310
Variant links:
Genes affected
ATP7B (HGNC:870): (ATPase copper transporting beta) This gene is a member of the P-type cation transport ATPase family and encodes a protein with several membrane-spanning domains, an ATPase consensus sequence, a hinge domain, a phosphorylation site, and at least 2 putative copper-binding sites. This protein is a monomer, and functions as a copper-transporting ATPase which exports copper out of the cells, such as the efflux of hepatic copper into the bile. Alternate transcriptional splice variants, encoding different isoforms with distinct cellular localizations, have been characterized. Mutations in this gene have been associated with Wilson disease which is characterized by copper accumulation. [provided by RefSeq, Dec 2019]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.2938263E-5).
BP6
Variant 13-51941218-A-G is Benign according to our data. Variant chr13-51941218-A-G is described in ClinVar as [Benign]. Clinvar id is 35720.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-51941218-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.591 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ATP7BNM_000053.4 linkuse as main transcriptc.3419T>C p.Val1140Ala missense_variant 16/21 ENST00000242839.10 NP_000044.2 P35670-1B7ZLR4A0A024RDX3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ATP7BENST00000242839.10 linkuse as main transcriptc.3419T>C p.Val1140Ala missense_variant 16/211 NM_000053.4 ENSP00000242839.5 P35670-1

Frequencies

GnomAD3 genomes
AF:
0.571
AC:
86732
AN:
151764
Hom.:
24894
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.556
Gnomad AMI
AF:
0.430
Gnomad AMR
AF:
0.602
Gnomad ASJ
AF:
0.569
Gnomad EAS
AF:
0.407
Gnomad SAS
AF:
0.523
Gnomad FIN
AF:
0.602
Gnomad MID
AF:
0.642
Gnomad NFE
AF:
0.587
Gnomad OTH
AF:
0.593
GnomAD3 exomes
AF:
0.569
AC:
142081
AN:
249554
Hom.:
40962
AF XY:
0.568
AC XY:
76841
AN XY:
135400
show subpopulations
Gnomad AFR exome
AF:
0.550
Gnomad AMR exome
AF:
0.637
Gnomad ASJ exome
AF:
0.575
Gnomad EAS exome
AF:
0.397
Gnomad SAS exome
AF:
0.521
Gnomad FIN exome
AF:
0.610
Gnomad NFE exome
AF:
0.583
Gnomad OTH exome
AF:
0.585
GnomAD4 exome
AF:
0.579
AC:
846900
AN:
1461602
Hom.:
246937
Cov.:
56
AF XY:
0.578
AC XY:
420148
AN XY:
727102
show subpopulations
Gnomad4 AFR exome
AF:
0.559
Gnomad4 AMR exome
AF:
0.635
Gnomad4 ASJ exome
AF:
0.574
Gnomad4 EAS exome
AF:
0.402
Gnomad4 SAS exome
AF:
0.521
Gnomad4 FIN exome
AF:
0.607
Gnomad4 NFE exome
AF:
0.587
Gnomad4 OTH exome
AF:
0.577
GnomAD4 genome
AF:
0.571
AC:
86795
AN:
151882
Hom.:
24911
Cov.:
30
AF XY:
0.571
AC XY:
42376
AN XY:
74224
show subpopulations
Gnomad4 AFR
AF:
0.556
Gnomad4 AMR
AF:
0.602
Gnomad4 ASJ
AF:
0.569
Gnomad4 EAS
AF:
0.408
Gnomad4 SAS
AF:
0.524
Gnomad4 FIN
AF:
0.602
Gnomad4 NFE
AF:
0.586
Gnomad4 OTH
AF:
0.595
Alfa
AF:
0.574
Hom.:
50171
Bravo
AF:
0.573
TwinsUK
AF:
0.586
AC:
2173
ALSPAC
AF:
0.590
AC:
2274
ESP6500AA
AF:
0.548
AC:
2112
ESP6500EA
AF:
0.591
AC:
4888
ExAC
AF:
0.565
AC:
68274
Asia WGS
AF:
0.529
AC:
1836
AN:
3478
EpiCase
AF:
0.591
EpiControl
AF:
0.591

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:19
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Wilson disease Benign:9
Benign, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthMar 05, 2018- -
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 01, 2021- -
Benign, criteria provided, single submitterclinical testingAll of Us Research Program, National Institutes of HealthOct 03, 2024- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaMar 06, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, no assertion criteria providedclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpNov 26, 2011- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesMar 08, 2022- -
not specified Benign:8
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Oct 19, 2017- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingGeneDxJan 05, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
not provided Uncertain:1Benign:1
Uncertain significance, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-multiple AR variants in same gene - keep for nowAllele frequency is common in at least one population database (frequency: 64.181% in ExAC) based on the frequency threshold of 2.434% for this gene.Variant was observed in a homozygous state in population databases more than expected for disease. -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJul 01, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.058
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
7.6
DANN
Benign
0.24
DEOGEN2
Uncertain
0.51
D;T;.;.;.;.;.
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.0047
N
LIST_S2
Benign
0.0056
T;T;T;T;T;T;T
MetaRNN
Benign
0.000013
T;T;T;T;T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
0.15
N;.;.;.;.;.;.
PrimateAI
Benign
0.25
T
PROVEAN
Benign
0.92
N;N;N;N;N;.;N
REVEL
Benign
0.19
Sift
Benign
0.91
T;T;T;T;T;.;T
Sift4G
Benign
1.0
T;T;T;T;T;T;T
Polyphen
0.0
B;B;B;B;B;B;B
Vest4
0.051
MPC
0.069
ClinPred
0.00030
T
GERP RS
0.087
Varity_R
0.030
gMVP
0.38

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1801249; hg19: chr13-52515354; COSMIC: COSV54438812; COSMIC: COSV54438812; API